Insufficient scRNA-seq data for expression of CLCN1 at single-cell level.
Insufficient scRNA-seq data for expression of CLCN1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 66% | 11.42 | 218 / 328 | 48% | 1.60 | 86 / 178 |
uterus | 78% | 18.62 | 133 / 170 | 29% | 0.89 | 134 / 459 |
muscle | 100% | 1637.34 | 803 / 803 | 0% | 0 | 0 / 0 |
breast | 81% | 23.56 | 373 / 459 | 8% | 0.16 | 86 / 1118 |
spleen | 83% | 17.88 | 200 / 241 | 0% | 0 | 0 / 0 |
thymus | 65% | 11.95 | 426 / 653 | 9% | 0.46 | 55 / 605 |
adipose | 67% | 12.37 | 804 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 65% | 31.84 | 606 / 929 | 0% | 0 | 0 / 0 |
esophagus | 44% | 23.65 | 640 / 1445 | 20% | 0.39 | 37 / 183 |
prostate | 60% | 22.74 | 147 / 245 | 2% | 0.04 | 9 / 502 |
intestine | 42% | 28.20 | 402 / 966 | 17% | 0.54 | 92 / 527 |
stomach | 30% | 6.19 | 108 / 359 | 22% | 0.49 | 63 / 286 |
lung | 38% | 4.90 | 222 / 578 | 11% | 0.26 | 124 / 1155 |
kidney | 46% | 8.79 | 41 / 89 | 2% | 0.04 | 19 / 901 |
bladder | 33% | 6.43 | 7 / 21 | 14% | 0.34 | 72 / 504 |
skin | 36% | 6.95 | 656 / 1809 | 4% | 0.15 | 17 / 472 |
brain | 35% | 5.79 | 917 / 2642 | 1% | 0.01 | 6 / 705 |
liver | 27% | 5.70 | 60 / 226 | 6% | 0.13 | 23 / 406 |
adrenal gland | 28% | 3.24 | 71 / 258 | 2% | 0.06 | 4 / 230 |
ovary | 17% | 2.02 | 31 / 180 | 5% | 0.09 | 20 / 430 |
blood vessel | 15% | 2.79 | 203 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.20 | 6 / 45 |
heart | 9% | 0.97 | 81 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.10 | 2 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1902476 | Biological process | chloride transmembrane transport |
GO_0006936 | Biological process | muscle contraction |
GO_0006821 | Biological process | chloride transport |
GO_0019227 | Biological process | neuronal action potential propagation |
GO_0042383 | Cellular component | sarcolemma |
GO_0034707 | Cellular component | chloride channel complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0005247 | Molecular function | voltage-gated chloride channel activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CLCN1 |
Protein name | Uncharacterized protein CLCN1 Chloride channel protein 1 (ClC-1) (Chloride channel protein, skeletal muscle) Chloride voltage-gated channel 1 |
Synonyms | CLC1 |
Description | FUNCTION: Voltage-gated chloride channel . Plays an important role in membrane repolarization in skeletal muscle cells after muscle contraction. The CLC channel family contains both chloride channels and proton-coupled anion transporters that exchange chloride or another anion for protons (Probable). The absence of conserved gating glutamate residues is typical for family members that function as channels (Probable). . |
Accessions | H7C0N6 Q75L28 P35523 A0A3B3IU72 ENST00000455478.6 ENST00000343257.7 ENST00000432192.6 ENST00000650516.2 H7C1F4 |